Browse Categories

Publications by authors named "RaKavius Chambers"

  • Page 1 of 1
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial.
Stephen J Greene RaKavius Chambers Joseph B Lerman Josephine Harrington Christopher R deFilippi

Eur J Heart Fail

June 2024

Article Synopsis
  • The PARACOR-19 trial investigated whether the medication sacubitril/valsartan could improve heart health markers in patients who had recently recovered from COVID-19.
  • In this study involving 42 participants, the drug did not significantly affect the primary cardiac injury markers, high-sensitivity cardiac troponin T and soluble ST2, compared to a placebo.
  • However, exploratory results showed that sacubitril/valsartan led to notable reductions in other heart-related biomarkers, indicating it might help in reducing cardiac stress and improving collagen turnover.
View Article and Find Full Text PDF
Privacy Policy Site Map

© LitMetric 2024. All rights reserved.

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session5pfatfjvie9mttplpov65nvnr7ad8cqi): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once